Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Dasher Neuroscience Inc.

Clinical trials sponsored by Dasher Neuroscience Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug YA-101 aims to slow rare brain disease Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

New drug YA-101 aims to slow rare brain disease

Disease control Ongoing

This Phase 2 trial tests the safety and effectiveness of YA-101, an oral drug, in 75 people with multiple system atrophy (MSA), a rare and progressive brain disorder. Participants will receive either YA-101 or a placebo twice daily for several weeks. The study will monitor side e…

Phase 2 • Sponsor: Dasher Neuroscience Inc. • Aim: Disease control

Last updated Aug 21, 2026 00:00 UTC